Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
British Medical Journal|August 22, 1970
Treatment of hypertension with clonidineA I MacDougall, G J Addis, N MacKay, et al.
The New England Journal of Medicine|December 30, 1982
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosisR Hull, J Hirsh, R Jay, et al.
Thrombosis Research|December 30, 2018
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugsS Galliazzo, M D Bianchi, A Virano, et al.
Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.
Lancet (London, England)|June 3, 1989
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeM Gent, J A Blakely, J D Easton, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
Pageof 21